RxDoctor Payments DataLook up a doctor →

Parvez Mantry, MD

Gastroenterology · Dallas, TXNPI 1770528697

Payments from drug & device makers

$6,366,007in general payments, 2019–2025

Across 2,656 payments — averaging $2396.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1.7M
  • Intercept Pharmaceuticals, Inc.$1.3M
  • AbbVie$683K
  • Sirtex Medical Inc$409K
  • Genentech, Inc.$339K
  • E.r. Squibb & Sons, L.L.C.$204K
  • plus $1.7M from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead531$1,716,787
Intercept Pharmaceuticals, Inc.485$1,302,879
AbbVie(2 entities)351$682,630
Sirtex Medical Inc100$409,113
Genentech, Inc.102$338,565
E.r. Squibb & Sons, L.L.C.13$204,074
Novo Nordisk83$199,075
Hoffmann-la Roche Limited28$173,118
Madrigal Pharmaceuticals86$153,856
Taiho Oncology, Inc.36$144,815
Bausch Health US, LLC87$134,970
Intercept Pharma Europe Ltd.52$118,489
Ipsen Bioscience Inc.85$115,925
Eisai Inc.91$97,162
Takeda Pharmaceuticals U.S.A., Inc.43$67,276
Regeneron34$60,478
Pfizer10$56,750
Amgen60$42,209
Astrazeneca UK Limited1$40,745
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC60$38,708
Shire North American Group Inc1$35,085
Ipsen Biopharmaceuticals, Inc23$33,527
Mallinckrodt Hospital Products Inc.16$31,049
Bristol Myers Squibb4$31,040
Merck18$30,929
GSK12$29,888
EMD Serono, Inc.10$22,800
Shionogi Inc10$13,027
Boston Scientific13$12,219
W. L. Gore & Associates, Inc.6$9,486
Johnson & Johnson(2 entities)7$4,255
Mallinckrodt Enterprises LLC6$4,181
Orphalan Inc2$3,149
Theratechnologies Inc.1$2,000
Genentech USA, Inc.4$1,530
Exelixis Inc.2$1,508
Novo Nordisk AS142$870
Dova Pharmaceuticals8$389
Mirum Pharmaceuticals, Inc.6$329
Perspectum Diagnostics Ltd3$194
Eurofins Viracor, LLC2$183
Exact Sciences2$126
Nuwellis, Inc.1$114
Sobi, Inc1$102
Apollo Endosurgery US Inc1$62
Siemens Medical Solutions USA, Inc.4$57
Laborie Medical Technologies Corp.1$38
Intra-sana Laboratories2$33
Conmed Corporation1$31
Alkermes, Inc.1$31
VBI Vaccine (delaware) Inc.1$27
Dynavax Technologies Corporation1$21
Medtronic1$20
Albireo Pharma, Inc.1$20
Vivus LLC1$19
Tetraphase Pharmaceuticals, Inc.1$18
Sanofi-aventis U.S. LLC1$16
Travere Therapeutics, Inc.1$14

How this compares

$6,366,007 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024
$82,015
Medicare patients
326
Services billed
705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →